#GoSAFE: mobility across the world being safe

Key facts

Disease
COVID-19
Known Financial Commitments (USD)
$554,386.13
Funder
European Commission
Principal Investigator
N/A
Research Location
Italy, Spain
…
Lead Research Institution
Engineering
Research Priority Alignment
N/A

Research Category
Health Systems Research
Research Subcategory
Health information systems
Special Interest Tags
Innovation
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

Innovation: The aim of #GoSAFE is to establish an interoperability model to enable cross border mobility during COVID-19 crisis, based on: (1) Solid national back offices providing information on people infected and (2) the GoSAFE BioSurveillance Kit BSK. The #GoSafe passport is a token or a tag (that can be physical or virtual). Once the user will log in to a generic system of a mobility operator, he/she will ask both for the ticket and at the same time for the virtual token for the assessment of his/her health status with respect to COVID-19. No other data of any other people will be requested from the application. Expected Results: GoSAFE's main goal is to create the conditions and the standards for an EU free COVID-19 passport, in other words a, '#GoSafe passport' that gives the holder the right to travel safely among different countries. The approach is totally privacy-preserving.

Publicationslinked via Europe PMC

Last Updated:4 hours ago

View all publications at Europe PMC

Developing injury and illness epidemiology and surveillance in cycling (PhD Academy Award).

Effects of Hand-Rearing and Group Size on Chimpanzee (Pan troglodytes) Social Competence in Captivity.

Revisiting Spirituality in Physical Therapy Practice: Perceptions of US Practitioners.

Aflibercept for Wet Age-Related Macular Degeneration: A Prospective, Randomized Trial Comparing Treat-And-Extend and Fixed Bimonthly Dosing.

The Concentration and Duration of Lipopolysaccharide Stimulation Produce Different Cytokine Responses in an Ex Vivo Whole Blood Model in Horses.

History of Shrimp Farming and the Main Viral and Bacterial Diseases in Mexico.

Identification of Risk Factors in Patients with Recurrent Cystitis May Improve Individualized Management.

ISApl4, a New IS1595 Family Insertion Sequence Forming a Novel Pseudo-Compound Transposon That Confers Antimicrobial Multidrug Resistance in Actinobacillus pleuropneumoniae.